title: Improvement of psoriatic arthritis by pioglitazone treatment in a type 2 diabetic patient.
authors.forename: M
authors.initials: M
authors.lastname: Takahara
authors.forename: T
authors.initials: T
authors.lastname: Shiraiwa
authors.forename: H
authors.initials: H
authors.lastname: Kaneto
authors.forename: T
authors.initials: T
authors.lastname: Yasuda
authors.forename: A
authors.initials: A
authors.lastname: Kuroda
authors.forename: F
authors.initials: F
authors.lastname: Sakamoto
authors.forename: T
authors.initials: T
authors.lastname: Naka
authors.forename: K
authors.initials: K
authors.lastname: Miyashita
authors.forename: K
authors.initials: K
authors.lastname: Sakamoto
authors.forename: T
authors.initials: T
authors.lastname: Matsuoka
authors.forename: I
authors.initials: I
authors.lastname: Shimomura
authors.forename: M
authors.initials: M
authors.lastname: Matsuhisa
mesh_terms: D015535:Arthritis, Psoriatic / Q000097:blood / Q000150:complications* / Q000188:drug therapy*; D002097:C-Reactive Protein / Q000032:analysis; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications* / Q000188:drug therapy*; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007333:Insulin Resistance; D008875:Middle Aged; D018384:Oxidative Stress / Q000187:drug effects; D000077205:Pioglitazone; D012720:Severity of Illness Index; D045162:Thiazolidinediones / Q000627:therapeutic use*
chemical_list: D002097:C-Reactive Protein; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D000077205:Pioglitazone; D045162:Thiazolidinediones; C517652:hemoglobin A1c protein, human